Skip to content
Medical Health Aged Care

Lighten the overload of Australia’s most common genetic disorder

Haemochromatosis Australia 2 mins read

MEDIA RELEASE

Optus Stadium and 100 other well-known buildings and landmarks across WA and Australia will turn red from tonight until 7 June, shining a light on an extremely common genetic condition that most people have never heard of.

It is part of a worldwide initiative to raise awareness of haemochromatosis – also known as iron overload – and to prompt people to get tested. Most people know that having too little iron in your body can cause anaemia, which is characterised by tiredness and lethargy, but few people know that the same symptoms can also be caused by having too much iron.

The hereditary condition, which is passed on from both biological parents, is simple to detect and treat but if undiagnosed or ignored can lead to serious and life-threatening illness, including liver disease and diabetes. One in seven Australians carry one copy of the defective gene, while and one in 200 Australians have two copies, which puts them at high risk of developing the condition.

Dr Dan Johnstone, an iron researcher who also has the condition, says early detection is key to minimising or preventing permanent damage. “Awareness of haemochromatosis is more important now than ever as early diagnosis will help save lives, cut health costs and reduce unnecessary suffering for so many individuals and families. Everybody is different; some people will have early symptoms of fatigue or joint aches while others won’t know they have the condition until the damage is already done. Anyone who suspects they may have this condition should ask their GP for a blood test. Haemochromatosis is not a burden in your life if you get on to it early. Early diagnosis is key to managing and reducing complications. It is usually managed by a regime of therapeutic blood donations, at an Australian Red Cross Lifeblood donor centre. This is a classic win-win situation, benefiting both the individual and the community,” said Dr Johnstone.

Haemochromatosis Australia spokesperson, Tony Moorhead, said, “Despite being the most common genetic disorder in Australia, haemochromatosis is often underdiagnosed because people don’t know about it and symptoms are non-specific. Unfortunately, most of those affected aren’t diagnosed until aged in their mid-forties and already suffering ill health. “There are people with the condition who should have been diagnosed decades earlier. This would have reduced the suffering, medical cost and even loss of life that results from iron overload. If haemochromatosis is detected early enough it is completely preventable – those affected need never get sick, they simply need to donate blood to maintain normal iron levels and their health.” Mr Moorhead says. “Hereditary haemochromatosis is estimated to cost Australia’s health system about $280 million annually and to add further cost burdens by compounding other chronic conditions.” Haemochromatosis is easy to test, simple to treat but tragic to ignore. -

 

ENDS Landmarks lighting up can be found here: www.ha.org.au/whats-on/world-haemochromatosis-week/lighten-the-overload/


Key Facts:

* Australia's most common genetic disorder, that most have never heard of

* World Haemochromatosis Awareness Week June 1 - 7 

*Interviews available 

* Landmarks lighting up in red can be found here: www.ha.org.au/whats-on/world-haemochromatosis-week/lighten-the-overload/


About us:

To find out more visit www.ha.org.au/haemochromatosis


Contact details:

Kellie Curtain M: 0412339690 [email protected] 

Media

More from this category

  • Medical Health Aged Care
  • 06/03/2026
  • 19:10
Claritas HealthTech Ltd

Claritas iPET(TM) Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPET™ for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPET™, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital…

  • Medical Health Aged Care
  • 06/03/2026
  • 15:57
Dementia Australia

Cronulla comes together for people impacted by dementia

Friday 6 March 2026 Cronulla comes together for people impacted by dementia Cronulla community members tied up their laces and showed up in force last weekend for the 2026 Cronulla Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 760 people walked, ran and jogged to the finish line to raise an impressive total of $103,430. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Cronulla community…

  • Contains:
  • Medical Health Aged Care
  • 06/03/2026
  • 12:06
Royal Australian College of GPs

TGA ignored as Victorian Government ‘shortcut’ puts women at risk: RACGP

The Royal Australian College of GPs (RACGP) has expressed disappointment that the Victorian Government has overridden repeated warnings from the Therapeutic Goods Administration (TGA) by allowing pharmacists to prescribe the contraceptive pill, undermining established medicines safety safeguards. The Victorian Government has, contrary to repeated TGA assessments, weakened its medicines safety regulations by enabling pharmacists, rather than medically trained prescribers, to initiate prescriptions for the oral contraceptive pill. RACGP Victoria Chair Dr Anita Muñoz said the announcement prioritises political expediency and industry lobbying over evidence‑based public health. “We are deeply disappointed that the Victorian Government appears to be listening to lobbyists…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.